Triamcinolone and Viokace drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Triamcinolone (triamcinolone) and Viokace (pancrelipase (amylase;lipase;protease)). Common drug interactions include atrial fibrillation among females.

The phase IV clinical study analyzes what interactions people have when they take Triamcinolone and Viokace. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Triamcinolone?

Triamcinolone has active ingredients of triamcinolone. eHealthMe is studying from 25,577 Triamcinolone users. Check the latest studies of Triamcinolone.

What is Viokace?

Viokace has active ingredients of pancrelipase (amylase;lipase;protease). eHealthMe is studying from 208 Viokace users. Check the latest studies of Viokace.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

13 people who take Triamcinolone and Viokace together, and have interactions are studied.

Triamcinolone and Viokace drug interactions.

What are the common drug interactions of Triamcinolone and Viokace, by gender? *:

female:

Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Pancreatic disorder
Ear neoplasm malignant (ear cancerous tumour)
Energy increased
Eye disorder
Headache (pain in head)
Nausea (feeling of having an urge to vomit)
Pruritus (severe itching of the skin)
Renal disorder (kidney disease)
Arthritis (form of joint disorder that involves inflammation of one or more joints)

male:

n/a

What are the common drug interactions of Triamcinolone and Viokace, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Cystic fibrosis (disease of the secretary glands)

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Vertigo
Energy increased
Eye disorder
Headache (pain in head)
Nausea (feeling of having an urge to vomit)
Pruritus (severe itching of the skin)
Renal disorder (kidney disease)
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Dysphonia (speech disorder attributable to a disorder of phonation)

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 8 people, 61.54%
Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 4 people, 30.77%
Primary Immunodeficiency Syndrome: 3 people, 23.08%
Pancreatic Disorder: 1 person, 7.69%
Cystic Fibrosis (disease of the secretary glands): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Triamcinolone and Viokace?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously